BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
China's GLP-1 landscape
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
PFA re-energizes afib market
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Thursday, September 19, 2024
Home
»
Topics
»
Drugs
» Immuno-oncology
Immuno-oncology
RSS
MDX-210 efficacy/safety trial begins in U.K.
Aug. 23, 1996
No Comments
Progenic's GMK undergoes phase III clinical trials
Aug. 23, 1996
No Comments
AltaRex awaits Canadian approval to begin Ovarex phase II/III trials
Aug. 23, 1996
No Comments
European approval sought for new Rebif indications
Aug. 23, 1996
No Comments
U.S. patent will issue covering GLIOMAB-H
Aug. 16, 1996
No Comments
BEC2, ImClone Systems' therapeutic vaccine protected under U.S. patent
Aug. 9, 1996
No Comments
Larifane shown effective in cervical dysplasia/cancer patients
July 26, 1996
No Comments
Humanized CD38 antibodies for cancer/autoimmune disease treatment
July 26, 1996
No Comments
Multikine enters Canadian phase I/II trial
July 12, 1996
No Comments
Antitumor vaccines described by University of Pennsylvania
July 5, 1996
No Comments
Previous
1
2
…
929
930
931
932
933
934
935
936
937
Next